May 17, 2013
Representatives of national health regulatory authorities from around the world convened in Moscow to discuss ways to harmonize regulatory standards for biotherapeutic medicines.
|
May 15, 2013
Program aims to develop a novel oral treatment.
|
May 14, 2013
FDA has released guidance on best practices for conducting and reporting pharmacoepidemiologic safety studies.
|
May 13, 2013
New Center for Pharmaceutical Advancement and Training increases number of experts and available tools in Sub-Saharan countries.
|
May 13, 2013
By:
Adeline Siew, PhD
Amgen and Zhejiang Beta Pharma have signed an agreement to form a joint venture to commercialize Amgen's Vectibix (panitumumab) in the Chinese market. The aim is to quickly and efficiently deliver Vectibix to patients in China. Vectibix is a fully human anti-epidermal growth factor receptor (EGFR) antibody approved by FDA for the treatment of metastatic colorectal cancer.
|
May 10, 2013
Evaluation system for single-use bags and assemblies is now available for onsite testing.
|
May 8, 2013
EMA clarifies biosimilars guidelines.
|
May 8, 2013
The FDA has accepted for review Merck's Biologics License Application for its investigational ragweed pollen sublingual allergy immunotherapy tablet.
|
May 1, 2013
By:
Adeline Siew, PhD
Genentech announced that FDA has approved Actemra (tocilizumab) for the treatment of polyarticular juvenile idiopathic arthritis (PJIA) in children aged two years and older.
|
|
